Influenza virus and sars-cov-2 vaccines

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Sandor, A.M.
    • Affiliation: School of Medicine, Department of Microbiology and Immunology
  • Sturdivant, M.S.
    • Affiliation: N.C. Cancer Hospital, UNC Lineberger Comprehensive Cancer Center
  • Ting, J.P.Y.
    • Affiliation: School of Medicine, Department of Microbiology and Immunology
Abstract
  • Seasonal influenza and the current COVID-19 pandemic represent looming global health challenges. Efficacious and safe vaccines remain the frontline tools for mitigating both influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced diseases. This review will discuss the existing strategies for influenza vaccines and how these strategies have informed SARS-CoV-2 vaccines. It will also discuss new vaccine platforms and potential challenges for both viruses.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Journal of Immunology
Journal volume
  • 206
Journal issue
  • 11
Page start
  • 2509
Page end
  • 2520
Language
  • English
ISSN
  • 0022-1767
Publisher
  • American Association of Immunologists

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details 2509.full.pdf 2021-12-13 Public Download